Middlemore Hospital

Auckland 2104

3 studies enrolling now · 26 studies all time

What they study most

Antimicrobial, Arterial Thrombosis, Atherosclerosis of Native Arteries of the Extremities, Bacteremia, Bronchopulmonary Dysplasia, Chronic Kidney Failure, Chronic Lymphocytic Leukemia, Community-acquired Pneumonia, Influenza, COVID-19, Compensated Cirrhosis, Coronary Artery Disease, Critically Ill, Cytopenia

Studies at this site

• EASi-KIDNEY™ (The Studies of Heart & Kidney Protection With BI 690517 in Combination With Empagliflozin) — Recruiting now
• Platform of Randomized Adaptive Clinical Trials in Critical Illness — Recruiting now
• A Study of Elritercept to Treat Anemia in Adults With Very Low, Low, or Intermediate Risk Myelodysplastic Syndromes (MDS) — Recruiting now
• Randomized, Embedded, Multifactorial Adaptive Platform Trial for Community- Acquired Pneumonia — Recruiting now
• Safety and Efficacy of Bimagrumab and Semaglutide in Adults Who Are Overweight or Obese — Completed
• A Study to Evaluate the Efficacy and Safety of Obinutuzumab in Participants With Systemic Lupus Erythematosus — Running, not enrolling
• Study of Bomedemstat in Participants With Essential Thrombocythemia (IMG-7289-CTP-201/MK-3543-003) — Completed
• PeriOperative ISchemic Evaluation-3 Trial — Completed
• Study for Participants With Ulcerative Colitis Previously Enrolled in Etrolizumab Phase II/III Studies — Stopped early
• Randomized Global Phase 3 Study to Evaluate the Impact on NASH With Fibrosis of Obeticholic Acid Treatment — Stopped early
• Randomized Placebo-controlled Trial of FCM as Treatment for Heart Failure With Iron Deficiency / and Sub-Study — Completed
• Bacteremia Antibiotic Length Actually Needed for Clinical Effectiveness — Completed
• Vascular Endothelial Growth Factor-B (VEGF-B) Blockade With the Monoclonal Antibody CSL346 in Subjects With Diabetic Kidney Disease — Completed
• Study Evaluating the Efficacy and Safety of Obeticholic Acid in Subjects With Compensated Cirrhosis Due to Nonalcoholic Steatohepatitis — Completed
• A Study to Evaluate the Benefit of Venetoclax Plus Rituximab Compared With Bendamustine Plus Rituximab in Participants With Relapsed or Refractory Chronic Lymphocytic Leukemia (CLL) — Completed
• ELUVIA™ Drug-eluting Stent Versus Zilver® PTX® Stent — Completed
• Clinical Study of the BARD® COVERA™ Arteriovenous (AV) Stent Graft — Completed
• Pacritinib Versus Best Available Therapy to Treat Patients With Myelofibrosis and Thrombocytopenia — Stopped early
• Safety Study of Anti-Macrophage Migration Inhibitory Factor (Anti-MIF) Antibody in Lupus Nephritis — Stopped early
• OPTIMIST-A Trial: Minimally-invasive Surfactant Therapy in Preterm Infants 25-28 Weeks Gestation on CPAP — Status unconfirmed
• Study to Evaluate the Long-term Safety of Etrolizumab in Participants With Moderate to Severe Ulcerative Colitis — Completed
• The EVOLVE II Clinical Trial To Assess the SYNERGY Stent System for the Treatment of Atherosclerotic Lesion(s) — Completed
• Efficacy, Pharmacokinetics, and Safety of Presatovir in Hospitalized Adults With Respiratory Syncytial Virus (RSV) Infection — Completed
• The Dual Antiplatelet Therapy Study (DAPT Study) — Completed
• Study of MEDI-524 (Motavizumab) for the Prophylaxis of Serious Respiratory Syncytial Virus (RSV) Disease in High-Risk Children — Completed
• Phase III Study to Investigate the Safety and Efficacy of Fermagate and Lanthanum Carbonate — Stopped early